Our latest Mission Focus Report highlights how microgravity research has successfully transformed the drug development landscape with two new groundbreaking achievements for terrestrial pharmaceutical and space-based manufacturing.

Through Redwire’s PIL-BOX technology currently operating on the International Space Station, these breakthroughs offer researchers opportunities to develop novel drug forms that could offer more potency, fewer side effects, or entirely new properties and the ability to use seed crystal templates for mass production back here on Earth.